Expression of inducible nitric oxide synthase (NOS) in bone marrow cells of myelodysplastic syndromes

Leukemia

Volumn 13, Issue 5, 1999, Pages 699-703

  Kitagawa, M ^a,b   Takahashi, M ^b   Yamaguchi, S ^b   Inoue, M ^a   Ogawa, S ^b   Hirokawa, K ^a   Kamiyama, R ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bone marrow; iNOS; Myelodysplastic syndromes

Indexed keywords

CD68 ANTIGEN; GAMMA INTERFERON; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033049595     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401407     Document Type: Article

References (44)

1. Delacretaz F, Schmidt P-M, Piguet D, Bachmann F, Costa J. The FAB classification (proposals) applied to bone marrow biopsy. Am J Clin Pathol 1987; 87: 180-186.
2. Jacobs A. Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol 1985; 38: 1201-1217.
3. Kitagawa M, Kamiyama R, Takemura T, Kasuga T. Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia. Virchows Arch B 1989; 57: 47-53.
4. Kitagawa M, Kamiyama R, Kasuga T. Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia. Hum Pathol 1993; 24: 359-363.
5. Raza A, Mundle S, Shetty V, Alvi S, Chopra H, Span L, Parcharidou A, Dar S, Venugopal P, Borok R, Gezer S, Showel J, Loew J, Robin E, Rifkin S, Alston D, Hernandez B, Shar R, Kaizer H, Gregory S. Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines. Int J Hematol 1996; 63: 265-278.
6. Kitagawa M, Yamaguchi S, Takahashi M, Tanizawa T, Hirokawa K, Kamiyama R. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia. Leukemia 1998; 12: 486-492.
7. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factor. Blood 1986; 67: 257-267.
8. Bot FJ, Schipper P, Breeders L, Deiwel R, Kaushansky K, Loewenberg B. Interleukin-1β also induces granulocyte-macrophage colony-stimulating factor in immature normal bone marrow cells. Blood 1990; 76: 307-311.
9. Ulich TR, del Castillo J, Guo K, Souza L. The hematologic effects of chronic administration of the monokines, tumor necrosis factor, interleukin-1, and granulocyte colony-stimulating factor on bone marrow and circulation. Am J Pathol 1989; 134: 149-159.
10. Slack JL, Nemunaitis J, Andrews DF, Singer JW. Regulation of cytokine and growth factor gene expression in human bone marrow stromal cells transformed with simian virus 40. Blood 1990; 75: 2319-2327.
11. Peschel C, Green I, Paul WE. Interleukin-4 induces a substance in bone marrow stromal cells that reversely inhibits factor-dependent and factor-independent cell proliferation. Blood 1989; 73: 1130-1141.
12. + hematopoietic progenitor cells. Blood 1990; 75: 2292-2298.
13. Murase T, Hotta T, Saito H, Ohno R. Effect of recombinant tumor necrosis factor on the colony growth of human leukemia progenitor cells and hematopoietic progenitor cells. Blood 1987; 69: 467-472.
14. Young MRI, Young ME, Wright MA. Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-γ plus tumor necrosis factor-α synergistically reduce suppressor cell activity. Int J Cancer 1990; 46: 245-250.
15. Slordal L, Warren DJ, Moore MAS. Protective effects of tumor necrosis factor on murine hematopoiesis during cycle-specific cytotoxic chemotherapy. Cancer Res 1990; 50: 4216-4220.
16. Kitagawa M, Saito I, Kuwata T, Yoshida S, Yamaguchi S, Takahashi M, Tanizawa T, Kamiyama R, Hirokawa K. Overexpression of tumor necrosis factor (TNF)-α and interferon (IFN)-γ by bone marrow cells from patients with myelodysplastic syndromes. Leukemia 1997; 11: 2049-2054.
17. Selleri C, Sato T, Raiola AM, Rotoli B, Young NS, Maciejewski JP. Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haematopoietic cells. Br J Haematol 1997; 99: 481-489.
18. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TNF-α and other growth factors in vivo; analysis by mRNA phenotyping. Science 1988; 241: 708-712.
19. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP. Diagnosis of chronic myeloid and acute lymphatic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988; 85: 5698-5702.
20. Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J Exp Med 1989; 169: 2191-2198.
21. Faille A, Prosch C. Prognostic value of in vitro bone marrow culture in refractory anemia with excess of myeloblasts. Scand J Haematol 1987; 20: 286-288.
22. Francis GE, Wing MA, Miller EJ, Berney JJ, Wonke B, Hoffbrand AV. Use of bone marrow culture in prediction of acute leukaemic transformation in preleukaemia. Lancet 1983; i: 1409-1412.
23. Oloffson T, Olsson I. Biochemical characterization of a leukemia-associated inhibitor (I.AI) suppressing normal granulopoiesis in vitro. Blood 1980; 55: 983-991.
24. Cukrova V, Neuwitova R, Vermak J, Neuwirt J. Inhibitor of normal granulopoiesis produced by cells of MDS patients. Neoplasia 1989; 36: 83-89.
25. Crown J, Jakubowski A, Gabrilove J. Interleukin-1 : biological effects in human hematopoiesis. Leuk Lymphoma 1993; 9: 433-440.
26. Wang S-Y, Ho C-K, Chen L-Y, Wang R-C, Huang M-H, Castro-Malaspina H, Moore MAS. Down-regulation of myelopoiesis by mediators inhibiting the production of macrophage-derived granulomonopoietic enhancing activity (GM-EA). Blood 1988; 72: 2001-2006.
27. Lindemann A, Ludwig W-D, Oster W, Mertelsmann R, Herrmann F. High-level secretion of tumor necrosis factor-α contributes to hematopoietic failure in hairy cell leukemia. Blood 1989; 73: 880-884.
28. Raza A, Gezer S, Mundle S, Gao X-Z, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, Loew J, Marcus B, Khan Z, Chaney C, Showel J, Gregory S, Preisler H. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 86: 268-276.
29. Bouscary D, Vos JD, Guesnu M, Jondeau K, Viguier F, Melle J, Picard F, Dreyfus F, Fontenay-Roupie M. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Leukemia 1997; 11: 839-845.
30. Raefsky EL, Platanias LC, Zoumbos NC, Young NS. Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol 1985; 135: 2507-2512.
31. Roodman GD, Bird A, Hutzler D, Montgomery W. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Hematol 1987; 15: 928-935.
32. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-γ. J Immunol 1986; 136: 4487-4495.
33. Nakao S, Yamaguchi M, Shiobara S, Yokoi T, Miyawaki T, Taniguchi T, Matsuda T. Interferon-γ gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 1992; 79: 2532-2535.
34. Nitico A, Young NS. Gamma-interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 1994; 120: 463-469.
35. Rosselli F, Sanceau J, Gluckman E, Wietzerbin J, Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous over-production of tumor necrosis factor α. Blood 1994; 83: 1216-1225.
36. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. New Engl J Med 1993; 329: 2002-2012.
37. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol 1989; 38: 1709-1715.
38. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
39. Maciejewski JP, Selleri C, Sato T, Cho HJ, Keefer LK, Nathan CF. Nitric oxide suppression of human hematopoiesis in vitro: contribution to inhibitory action of interferon-γ and tumor necrosis factor-α. J Clin Invest 1995; 96: 1085-1092.
40. Lu L, Bonham CA, Chambers FG, Watkins SC, Houffman RA, Simmons RL, Thomson AW. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol 1996; 157: 3577-3586.
41. Wallerath T, Gath I, Aulitzky WE, Pollock JS, Kleinert H, Forstermann U. Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets. Thromb Haemost 1997; 77: 163-167.
42. Wang W, Keller K, Chadee K. Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production by macrophages for cytotoxicity against amoebae and tumour cells. Immunology 1994; 83: 601-610.
43. Kiemer AK, Vollmar AM. Autocrine regulation of inducible nitric-oxide synthase in macrophage by atrial natriuretic peptide. J Biol Chem 1998; 273: 13444-13451.
44. Drapier J-C, Wietzerbin J, Hibbs Jr JB. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 1988; 18: 1587-1592.